PASG

Passage Bio Inc

NASDAQ: PASG · HEALTHCARE · BIOTECHNOLOGY

$4.52

-1.09% today

Updated 2026-07-29

Market cap

$14.68M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-11.89

Dividend yield

—

52W range

$3 – $20

Volume

0.1M

Market cap

$14.68M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-11.89

Dividend yield

—

52W range

$3 – $20

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-17.5

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$15.50

+242.92%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.49x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -17.52 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-12.99M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-136.13M	$-102.06M	$-64.77M	$-45.52M	$-7.56M
EPS	—	—	—	—	$-11.89
Free cash flow	$-123.48M	$-78.41M	$-47.99M	$-31.51M	$-12.99M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PASG	$14.68M	28	4.3	3.0	5.0	4.5	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Passage Bio Inc trades at $4.52. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -17.52, it sits in the distress.

Frequently asked questions

What is Passage Bio Inc's stock price?

Passage Bio Inc (PASG) trades at $4.52.

Is Passage Bio Inc overvalued?

Passage Bio Inc carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Passage Bio Inc (PASG)?

The 12-month analyst consensus target is $15.50, about 242.9% above the current $4.52. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Passage Bio Inc's Altman Z-Score is -17.52, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-320.59%

Beta1.42

50D MA$5.18

200D MA$8.07

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PASG vs LLY →PASG vs JNJ →PASG vs ABBV →Stock screener →